Porous composites with high-aspect ratio crystals

Patent metadata

Field	Value
Publication number	US-12458732-B2
Application number	US-202117513013-A
Country	US
Kind code	B2
Filing date	Oct 28, 2021
Priority date	Mar 14, 2013
Publication date	Nov 4, 2025
Grant date	Nov 4, 2025

Abstract

The present disclosure is directed toward composite materials comprising high aspect ratio habits of drug crystals which can be partially or fully extending into a substrate, and additionally, can be projecting from a substrate at an angle of about 20° to about 90°. The present disclosure is directed toward medical devices, such as medical balloons, comprising said composite and methods of using and making the same. The described composite can be used for the local treatment of vascular disease. The present disclosure is also directed toward paclitaxel crystals with a hollow acicular habit.

First claim

What is claimed is:

1 . A method of preparing a composite comprising a porous substrate comprising ePTFE and a plurality of high aspect paclitaxel crystals, the crystals at least partially extending into the substrate and projected from the substrate at an angle of about 20 to 90 degrees with respect to the substrate and each having an axes dimension;
wherein said plurality of high aspect ratio paclitaxel crystals exhibits a non-reversing endotherm at a temperature of about 215 degrees C., wherein the porous substrate is compressible in the thickness dimension and wherein the projected crystals are not compressible in their axes dimension; the method comprising the steps of: preparing a solution of paclitaxel in an organic solvent comprising methanol, wherein the organic solvent is capable of wetting the substrate; applying the solution to the surface of the porous substrate; and causing the solvent to evaporate to form the paclitaxel crystal.

2 . The method of claim 1 , wherein the paclitaxel crystals are hollow, acicular crystals.

3 . The method of claim 1 , further comprising the step of treating the composite with at least one of solvent annealing, vapor annealing, and thermal annealing.

4 . The method of claim 1 , wherein applying the solution comprises at least one of pipetting, dipping and spraying.

5 . The method of claim 1 , further comprising the step of applying at least one of water, and ethyl acetate.

6 . The method of claim 1 , wherein the porous substrate forms a surface of a medical device.

7 . The method of claim 6 , wherein the medical device is a catheter-based device selected from a stent, a stent graft and a balloon.

Assignees

• Gore & Ass

Inventors

• Cleek Robert L
• Cully Edward H
• Drumheller Paul D
• Li Mei
• Traylor Peter D

Classifications

• A61L2300/416

  Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus · CPC title

• A61L2300/63

  Crystals · CPC title

• A61L2400/18

  Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment · CPC title

• A61L29/085

  Macromolecular materials · CPC title

• A61L29/146

  Porous materials, e.g. foams or sponges · CPC title